Evidence map›Paper›PMID 26281716›Full record

ReviewBiological psychiatry2016

Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia.

Monika P Jadi, M Margarita Behrens, Terrence J Sejnowski

Open access · greenAbstract readReview
In one paragraph

Review in Biological psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Synaptic dysfunction and adaptation after NMDA receptor ablation in the mouse medial prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  8. Article
  9. Review
  10. Effects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Discovery of VU6024578/BI02982816: An mGluJournal of medicinal chemistry · 2024
    Article
  16. Review
  17. Article
  18. 40 Hz Steady-State Response in Human Auditory Cortex Is Shaped by Gabaergic Neuronal Inhibition.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Monika P JadiHoward Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, California; Division of Biological Sciences, University of California at San Diego, La Jolla, California. Electronic address: jadi@salk.edu.
M Margarita BehrensHoward Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, California.
Terrence J SejnowskiHoward Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, California; Division of Biological Sciences, University of California at San Diego, La Jolla, California.
Howard Hughes Medical Institute · USSalk Institute for Biological Studies · USUniversity of California, San Diego · US

Funding

TRAINING PROGRAM IN COGNITIVE NEUROSCIENCET32MH020002 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SEJNOWSKI, TERRENCE J · 1999 to 2020
$6.1M
Epigenetic Alterations of the Developing Brain in Animal Models of SchizophreniaR01MH094670 · NIMH · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI BEHRENS, M MARGARITA, ECKER, JOSEPH R · 2011 to 2015
$3.6M
Sensitive and Treatable Periods of Brain-Redox Imbalance in SchizophreniaR01MH091407 · NIMH · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI BEHRENS, M MARGARITA, POWELL, SUSAN B · 2010 to 2014
$2.1M
Cholinergic modulation of cortical visual processingK99EY025026 · NEI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI JADI, MONIKA P. · 2015 to 2016
$189k
Howard Hughes Medical InstituteNEI NIH HHS K99 EY025026NIMH NIH HHS MH091407NIMH NIH HHS MH094670NIMH NIH HHS R01 MH091407NIMH NIH HHS R01 MH094670NIMH NIH HHS T32 MH020002NIMH NIH HHS T32MH020002
6 · The paper itself

Abstract

N-methyl-D-aspartate receptor (NMDAR) hypofunction in parvalbumin-expressing (PV+) inhibitory neurons (INs) may contribute to symptoms in patients with schizophrenia (SZ). This hypothesis was inspired by studies in humans involving NMDAR antagonists that trigger SZ symptoms. Animal models of SZ using neuropharmacology and genetic knockouts have successfully replicated some of the key observations in human subjects involving alteration of gamma band oscillations (GBO) observed in electroencephalography and magnetoencephalography signals. However, it remains to be seen if NMDAR hypofunction in PV+ neurons is fundamental to the phenotype observed in these models. In this review, we discuss some of the key computational models of GBO and their predictions in the context of NMDAR hypofunction in INs. While PV+ INs have been the main focus of SZ studies in animal models, we also discuss the implications of NMDAR hypofunction in other types of INs using computational models for GBO modulation in the visual cortex.

Indexed as

Gamma RhythmModels, NeurologicalAction PotentialsAnimalsCerebral CortexElectroencephalographyGABAergic Neuronsgamma-Aminobutyric AcidHumansInterneuronsParvalbuminsReceptors, N-Methyl-D-AspartateSchizophreniagamma-Aminobutyric AcidParvalbuminsReceptors, N-Methyl-D-AspartateComputational modelsGamma oscillationsInhibitionNMDA hypofunctionParvalbuminSchizophrenia

Identifiers

PMID26281716
PMCPMC4720598
OpenAlexW1195039153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.